{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-007447","form_type":"8-K","ticker":"ROIV","cik":"0001635088","company_name":"Roivant Sciences Ltd.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.700565+00:00","generated_at":"2026-05-15T22:17:22.720963+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"FDA accepts brepocitinib NDA for dermatomyositis, grants Priority Review; PDUFA Q3 2026","bullets":["FDA accepted NDA and granted Priority Review for brepocitinib in dermatomyositis; PDUFA target action date in Q3 2026.","Launch expected at end of September 2026 if approved; supported by positive Phase 3 VALOR trial (N=241).","VALOR was first positive 52-week placebo-controlled study in dermatomyositis; brepocitinib 30mg met primary endpoint and all nine key secondary endpoints.","If approved, brepocitinib would be first targeted therapy for dermatomyositis; safety profile similar to approved JAK/TYK2 inhibitors."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-007447","json":"https://secwatch.observer/filing/0001140361-26-007447.json","markdown":"https://secwatch.observer/filing/0001140361-26-007447.md","text":"https://secwatch.observer/filing/0001140361-26-007447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126007447/0001140361-26-007447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126007447/ef20066998_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:17:22.720963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}